Easy Money: could very well happen. AMBS could sell a sizeable stake in Lympro which would accomplish 2 things. 1) provide needed money now to push other programs forward, and 2) hold the asset to build value in CLIA for an eventual sale. Very plausible. Makes biz sense.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links